Skip to main content

Published locations for HR+/ERBB2+ early BC: Excellent pCR rate with de-escalated neoadjuvant paclitaxel plus trastuzumab and pertuzumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HR+/ERBB2+ early BC: Excellent pCR rate with de-escalated neoadjuvant paclitaxel plus trastuzumab and pertuzumab

User login

  • Reset your password
  • /content/hr/erbb2-early-bc-excellent-pcr-rate-de-escalated-neoadjuvant-paclitaxel-plus-trastuzumab
  • /hematology-oncology/article/263620/breast-cancer/hr/erbb2-early-bc-excellent-pcr-rate-de-escalated